Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide/Dexamethasone vs VAD in Newly Diagnosed Myeloma
NCT00215943Phase 3Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Jun 2003
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Moffitt Cancer Center. Started Jun 2003; status: terminated.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00215943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215943.